Effects of the New Class-III Antiarrhythmic Drug D-Sotalol on Contractile Function of Postischemic Myocardium

Journal of Cardiovascular Pharmacology ◽

10.1097/00005344-199104000-00009 ◽

1991 ◽

Vol 17 (4) ◽

pp. 581-586 ◽

Author(s):

Hans Martin Hoffineister ◽

Susanne Müller ◽

Ludger Scipel

Keyword(s):

Antiarrhythmic Drug ◽

Contractile Function ◽

Class Iii ◽

New Class ◽

Class Iii Antiarrhythmic Drug ◽

Postischemic Myocardium

Download Full-text

Dofetilide, a New Class III Antiarrhythmic Drug Reduces Hospital Admissions for Congestive Heart Failure - Secondary Endpoints of the DIAMOND-CHF Study

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(97)83859-4 ◽

1998 ◽

Vol 31 (2) ◽

pp. 33A ◽

Author(s):

L Kaber

Keyword(s):

Heart Failure ◽

Congestive Heart Failure ◽

Antiarrhythmic Drug ◽

Hospital Admissions ◽

Class Iii ◽

New Class ◽

Class Iii Antiarrhythmic Drug ◽

Secondary Endpoints

Download Full-text

Effects of Azimilide, a New Class III Antiarrhythmic Drug, on Reentrant Circuits Causing Ventricular Tachycardia and Fibrillation in a Canine Model of Myocardial Infarction

Journal of Cardiovascular Electrophysiology ◽

10.1046/j.1540-8167.2001.01025.x ◽

2001 ◽

Vol 12 (9) ◽

pp. 1025-1033 ◽

Author(s):

HEIKO SCHMITT ◽

CANDIDO CABO ◽

JAMES C. COROMILAS ◽

ANDREW L. WIT

Keyword(s):

Myocardial Infarction ◽

Ventricular Tachycardia ◽

Antiarrhythmic Drug ◽

Canine Model ◽

Class Iii ◽

New Class ◽

Class Iii Antiarrhythmic Drug ◽

Ventricular Tachycardia And Fibrillation

Download Full-text

Electrophysiologic Effects of the New Class III Antiarrhythmic Drug Dofetilide Compared to the Class IA Antiarrhythmic Drug Quinidine in Experimental Canine Atrial Flutter:.

Journal of Cardiovascular Electrophysiology ◽

10.1111/j.1540-8167.1996.tb00594.x ◽

1996 ◽

Vol 7 (9) ◽

pp. 809-827 ◽

Author(s):

YONGMEI CHA ◽

ALAN WALES ◽

PAUL WOLF ◽

SHAHIN SHAHROKNI ◽

NEIL SAWHNEY ◽

...

Keyword(s):

Atrial Flutter ◽

Antiarrhythmic Drug ◽

Class Iii ◽

New Class ◽

Class Iii Antiarrhythmic Drug ◽

Experimental Canine

Download Full-text

Electrophysiologic Effects of the New Class III Antiarrhythmic Drug Dofetilide in an Experimental Canine Model of Pacing-induced Atrial Fibrillation

Journal of Cardiovascular Pharmacology and Therapeutics ◽

10.1177/107424849700200306 ◽

1997 ◽

Vol 2 (3) ◽

pp. 195-203 ◽

Author(s):

Gregory K. Feld ◽

Yongmei Cha

Keyword(s):

Atrial Fibrillation ◽

Antiarrhythmic Drug ◽

Canine Model ◽

Class Iii ◽

New Class ◽

Class Iii Antiarrhythmic Drug ◽

Experimental Canine

Download Full-text

P2104 Effects of a new class III antiarrhythmic drug nibentan in a canine model of spontaneous atrial fibrillation

European Heart Journal ◽

10.1016/s0195-668x(03)95098-6 ◽

2003 ◽

Vol 24 (5) ◽

pp. 391

Author(s):

V FEDOROV

Keyword(s):

Atrial Fibrillation ◽

Antiarrhythmic Drug ◽

Canine Model ◽

Class Iii ◽

New Class ◽

Class Iii Antiarrhythmic Drug

Download Full-text

Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes

British Journal of Pharmacology ◽

10.1111/j.1476-5381.1993.tb13546.x ◽

1993 ◽

Vol 109 (1) ◽

pp. 157-163 ◽

Author(s):

Haruaki Nakaya ◽

Noritsugu Tohse ◽

Youji Takeda ◽

Morio Kanno

Keyword(s):

Action Potential ◽

Antiarrhythmic Drug ◽

Ventricular Myocytes ◽

Membrane Currents ◽

Class Iii ◽

New Class ◽

Class Iii Antiarrhythmic Drug ◽

Rabbit Ventricular Myocytes

Download Full-text

Direct coupled column separation and determination of the diastereomeric glucuronides of almokalant, a new class III antiarrhythmic drug, in human urine

Chirality ◽

10.1002/chir.530040809 ◽

1992 ◽

Vol 4 (8) ◽

pp. 509-514 ◽

Author(s):

Morgan Stefansson ◽

Kurt-J�rgen Hoffmann

Keyword(s):

Antiarrhythmic Drug ◽

Human Urine ◽

Class Iii ◽

New Class ◽

Column Separation ◽

Class Iii Antiarrhythmic Drug

Download Full-text

Effect of E-4031, a new class III antiarrhythmic drug, on reentrant ventricular arrhythmias: Comparison with conventional class I drugs

Cardiovascular Drugs and Therapy ◽

10.1007/bf00877629 ◽

1993 ◽

Vol 7 (S3) ◽

pp. 621-626 ◽

Author(s):

Satoshi Ogawa ◽

Hideo Mitamura ◽

Hiroshi Katoh

Keyword(s):

Antiarrhythmic Drug ◽

Ventricular Arrhythmias ◽

Class I ◽

Class Iii ◽

New Class ◽

Class Iii Antiarrhythmic Drug

Download Full-text

Effects of MS-551, a New Class III Antiarrhythmic Drug, on Programmed Stimulation-Induced Ventricular Arrhythmias, Electrophysiology, and Hemodynamics in a Canine Myocardial Infarction Model

Journal of Cardiovascular Pharmacology ◽

10.1097/00005344-199404000-00024 ◽

1994 ◽

Vol 23 (4) ◽

pp. 674-680 ◽

Author(s):

Kazunao Kondoh ◽

Hisakuni Hashimoto ◽

Hiroshi Nishiyama ◽

Kazuo Umemura ◽

Tooru Ozaki ◽

...

Keyword(s):

Myocardial Infarction ◽

Antiarrhythmic Drug ◽

Ventricular Arrhythmias ◽

Class Iii ◽

New Class ◽

Programmed Stimulation ◽

Class Iii Antiarrhythmic Drug ◽

Canine Myocardial Infarction

Download Full-text

Electrophysiologic profile and efficacy of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with sustained monomorphic ventricular tachycardia

The American Journal of Cardiology ◽

10.1016/s0002-9149(99)80293-8 ◽

1995 ◽

Vol 76 (14) ◽

pp. 1040-1044 ◽

Author(s):

Yaves Bashir ◽

Poul-Erik B. Thomsen ◽

J.Herre Kingma ◽

Mogens Møller ◽

Christopher Wong ◽

...

Keyword(s):

Ventricular Tachycardia ◽

Antiarrhythmic Drug ◽

Class Iii ◽

New Class ◽

Monomorphic Ventricular Tachycardia ◽

Class Iii Antiarrhythmic Drug

Download Full-text